Abstract
Failure of ELM-PC 5: an ineffective drug or an unfit end point?
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Paper Title
Journal
Date